Refine
Has Fulltext
- yes (57)
Is part of the Bibliography
- yes (57)
Year of publication
Document Type
- Journal article (57)
Language
- English (57) (remove)
Keywords
- Parkinson’s disease (15)
- deep brain stimulation (13)
- Parkinson's disease (8)
- subthalamic nucleus (6)
- dopamine (5)
- neuroinflammation (5)
- basal ganglia (4)
- cervical dystonia (3)
- ischemic stroke (3)
- length of stenosis (3)
- mesencephalic locomotor region (3)
- neurodegeneration (3)
- photothrombotic stroke (3)
- stroke (3)
- tremor (3)
- Parkinson disease (2)
- T cells (2)
- base of support (2)
- carotid atherosclerosis (2)
- carotid stenosis (2)
- carotid ultrasound (2)
- cerebellar tDCS (2)
- degree of stenosis (2)
- dementia (2)
- disease (2)
- dystonia (2)
- essential tremor (2)
- gait (2)
- gait initiation (2)
- local field potentials (2)
- locus coeruleus (2)
- movement disorders (2)
- multiple sclerosis (2)
- neuroprotection (2)
- outcomes (2)
- second hit (2)
- split-belt treadmill (2)
- walking (2)
- 5IA-SPECT (1)
- A53T (1)
- Alzheimer’s disease (1)
- Amplitude (1)
- BDNF (1)
- Braak (1)
- DARPA (1)
- DBS biomarkers (1)
- DBS programming (1)
- DOPA-responsive-dystonia (1)
- DRD1 (1)
- DYT1 (1)
- Dystonia (1)
- F-18-FDG PET (1)
- GCH1 (1)
- GFAP (1)
- GFAP-astrocytopathies (1)
- GPCR (1)
- LSVT-big therapy (1)
- Lewy-like pathology (1)
- MCC950 (1)
- MIBG scintigraphy (1)
- NLRP3 (1)
- NPC1 gene (1)
- NPC2 gene (1)
- Niemann–Pick disease type C (1)
- Parkinson (1)
- Parkinsons disease (1)
- Parkionson's disease (1)
- Pointing error (1)
- Proprioception (1)
- Tourette syndrome (1)
- Training (1)
- TrkB (1)
- [18F]FDG positron emission tomography (1)
- accuracy (1)
- adult-onset (1)
- alpha-7 nicotinic acetylcholine receptor (1)
- ankles (1)
- anthropometric measurement (1)
- anthropometric measurements (1)
- antigen-presenting cells (1)
- apomorphine (1)
- areas (1)
- arm (1)
- autoantibodies (1)
- balance (1)
- beta oscillation (1)
- beta oscillations (1)
- beta power (1)
- bilateral internal carotid artery stenosis (1)
- binding (1)
- biological locomotion (1)
- blood-brain barrier (1)
- botulinum toxin (1)
- brain (1)
- brain metabolic alterations (1)
- brain networks (1)
- brain stem (1)
- care tempis (1)
- cerebellum (1)
- children (1)
- choline acetyltransferase (1)
- cholinergic activity (1)
- chronic stimulation (1)
- clinical approach (1)
- clinical diagnosis (1)
- clinical outcome (1)
- closed-loop (1)
- cognitive decline (1)
- coherence analysis (1)
- computer vision (1)
- consolidation (1)
- continuous theta burst stimulation (cTBS) (1)
- coordination (1)
- cortical excitability (1)
- cortical silent period (1)
- cortico-striatal synapse (1)
- criteria (1)
- dSPN (1)
- deep brain stimulation (DBS) (1)
- depression (1)
- diagnostic markers (1)
- digital medicine (1)
- direct pathway (1)
- directional deep brain stimulation (1)
- dopamine acetylcholine (1)
- dopaminergic cells (1)
- duodenal levodopa infusion (1)
- exome sequencing (1)
- experimental stroke (1)
- eye movement disorders (1)
- family caregiver (1)
- freezing of gait (1)
- freezing of gait (FOG) (1)
- functional MRI (1)
- functional neuroanatomy (1)
- future directions (1)
- gene-environment interaction (1)
- globus pallidus pars interna (GPi) (1)
- guidelines (1)
- high contrast (1)
- hospitals (1)
- human neurons (1)
- image-guided programming (1)
- imaging (1)
- induced neural stem cells (1)
- infarction volume (1)
- inflammasome (1)
- informal care (1)
- internal carotid artery stenosis (1)
- invasive electric stimulation (1)
- just noticeable difference (JND) (1)
- kinematics (1)
- levodopa-induced dyskinesia (1)
- locomotor adaptation (1)
- major depression (1)
- microglia (1)
- mortality (1)
- motor control (1)
- motor learning (1)
- motor-evoked potentials (MEP) (1)
- mouse model (1)
- movement (1)
- movement disorder (1)
- movements (1)
- multiple system atrophy (1)
- musical syntax (1)
- mutation (1)
- neuroimmunology (1)
- neurology (1)
- neuronal apoptosis (1)
- neuronal network (1)
- neurophysiology (1)
- neuroscience (1)
- nicotinic receptors (1)
- non-motor features (1)
- noradrenalin (1)
- noradrenaline (1)
- norepinephrine (1)
- nucleus ventralis intermedius (1)
- nystagmus (1)
- outcome (1)
- pallidal stimulation (1)
- parkinson disease (1)
- parkinsons disease (1)
- pathophysiology (1)
- pedunculopontine nucleus (PPN) (1)
- peripheral injury (1)
- peripheral nervous system (1)
- pet (1)
- photothrombosis (1)
- physical therapy modalities (1)
- pilot project (1)
- plaque cross-sectional area (1)
- plasma oxysterols (1)
- post-traumatic stress disorder (1)
- posture (1)
- precision medicine (1)
- progression (1)
- psychophysics (1)
- quality (1)
- randomized controlled double-blind study (1)
- randomized controlled trial (1)
- rat (1)
- reach-to-grasp movement (1)
- regulatory T cells (1)
- reserpinized rat model (1)
- resting tremor (1)
- rett (1)
- rhythm perception (1)
- risk (1)
- risk of fall (1)
- segmental centers of mass (1)
- skilled forelimb movements (1)
- skin biopsy (1)
- soleus muscles (1)
- spinal-cord (1)
- stimulation (1)
- stroke care (1)
- subthalamic nucleus (STN) (1)
- synapse (1)
- synaptic plasticity (1)
- synaptic vesicles (1)
- syndrome (1)
- target considerations (1)
- telemedicine (1)
- telemedicine network (1)
- term follow-up (1)
- thrombolysis (1)
- tight junctions (1)
- time (1)
- time perception (1)
- transcranial magnetic simulation (TMS) (1)
- transient ischemic attack (1)
- transmission electron microscopy (1)
- treatment-resistant depression (1)
- velocity (1)
- vertebrobasilar insufficiency (1)
- vertigo (1)
- vestibular (1)
- videooculography (1)
- white matter lesions (1)
- α-synuclein (1)
- α-synuclein-specific T cells (1)
Institute
- Neurologische Klinik und Poliklinik (57) (remove)
Highlights
• Dopamine receptor-1 activation induces TrkB cell-surface expression in striatal neurons
• Dopaminergic deficits cause TrkB accumulation and clustering in the ER
• TrkB clusters colocalize with cargo receptor SORCS-2 in direct pathway striatal neurons
• Intracellular TrkB clusters fail to fuse with lysosomes after dopamine depletion
Summary
Disturbed motor control is a hallmark of Parkinson’s disease (PD). Cortico-striatal synapses play a central role in motor learning and adaption, and brain-derived neurotrophic factor (BDNF) from cortico-striatal afferents modulates their plasticity via TrkB in striatal medium spiny projection neurons (SPNs). We studied the role of dopamine in modulating the sensitivity of direct pathway SPNs (dSPNs) to BDNF in cultures of fluorescence-activated cell sorting (FACS)-enriched D1-expressing SPNs and 6-hydroxydopamine (6-OHDA)-treated rats. DRD1 activation causes enhanced TrkB translocation to the cell surface and increased sensitivity for BDNF. In contrast, dopamine depletion in cultured dSPN neurons, 6-OHDA-treated rats, and postmortem brain of patients with PD reduces BDNF responsiveness and causes formation of intracellular TrkB clusters. These clusters associate with sortilin related VPS10 domain containing receptor 2 (SORCS-2) in multivesicular-like structures, which apparently protects them from lysosomal degradation. Thus, impaired TrkB processing might contribute to disturbed motor function in PD.
Neuroinflammation has been suggested as a pathogenetic mechanism contributing to Parkinson’s disease (PD). However, anti-inflammatory treatment strategies have not yet been established as a therapeutic option for PD patients. We have used a human α-synuclein mouse model of progressive PD to examine the anti-inflammatory and neuroprotective effects of inflammasome inhibition on dopaminergic (DA) neurons in the substantia nigra (SN). As the NLRP3 (NOD-, LRR- and pyrin domain-containing 3)-inflammasome is a core interface for both adaptive and innate inflammation and is also highly druggable, we investigated the implications of its inhibition. Repeat administration of MCC950, an inhibitor of NLRP3, in a PD model with ongoing pathology reduced CD4\(^+\) and CD8\(^+\) T cell infiltration into the SN. Furthermore, the anti-inflammasome treatment mitigated microglial activation and modified the aggregation of α-synuclein protein in DA neurons. MCC950-treated mice showed significantly less neurodegeneration of DA neurons and a reduction in PD-related motor behavior. In summary, early inflammasome inhibition can reduce neuroinflammation and prevent DA cell death in an α-synuclein mouse model for progressive PD.
The pathophysiology of tremor in Parkinson’s disease (PD) is evolving towards a complex alteration to monoaminergic innervation, and increasing evidence suggests a key role of the locus coeruleus noradrenergic system (LC-NA). However, the difficulties in imaging LC-NA in patients challenge its direct investigation. To this end, we studied the development of tremor in a reserpinized rat model of PD, with or without a selective lesioning of LC-NA innervation with the neurotoxin DSP-4. Eight male rats (Sprague Dawley) received DSP-4 (50 mg/kg) two weeks prior to reserpine injection (10 mg/kg) (DR-group), while seven male animals received only reserpine treatment (R-group). Tremor, rigidity, hypokinesia, postural flexion and postural immobility were scored before and after 20, 40, 60, 80, 120 and 180 min of reserpine injection. Tremor was assessed visually and with accelerometers. The injection of DSP-4 induced a severe reduction in LC-NA terminal axons (DR-group: 0.024 ± 0.01 vs. R-group: 0.27 ± 0.04 axons/um\(^2\), p < 0.001) and was associated with significantly less tremor, as compared to the R-group (peak tremor score, DR-group: 0.5 ± 0.8 vs. R-group: 1.6 ± 0.5; p < 0.01). Kinematic measurement confirmed the clinical data (tremor consistency (% of tremor during 180 s recording), DR-group: 37.9 ± 35.8 vs. R-group: 69.3 ± 29.6; p < 0.05). Akinetic–rigid symptoms did not differ between the DR- and R-groups. Our results provide preliminary causal evidence for a critical role of LC-NA innervation in the development of PD tremor and foster the development of targeted therapies for PD patients.
Topological differences and confounders of mental rotation in cervical dystonia and blepharospasm
(2023)
Mental rotation (mR) bases on imagination of actual movements. It remains unclear whether there is a specific pattern of mR impairment in focal dystonia. We aimed to investigate mR in patients with cervical dystonia (CD) and blepharospasm (BS) and to assess potential confounders. 23 CD patients and 23 healthy controls (HC) as well as 21 BS and 19 hemifacial spasm (HS) patients were matched for sex, age, and education level. Handedness, finger dexterity, general reaction time, and cognitive status were assessed. Disease severity was evaluated by clinical scales. During mR, photographs of body parts (head, hand, or foot) and a non-corporal object (car) were displayed at different angles rotated within their plane. Subjects were asked to judge laterality of the presented image by keystroke. Both speed and correctness were evaluated. Compared to HC, CD and HS patients performed worse in mR of hands, whereas BS group showed comparable performance. There was a significant association of prolonged mR reaction time (RT) with reduced MoCA scores and with increased RT in an unspecific reaction speed task. After exclusion of cognitively impaired patients, increased RT in the mR of hands was confined to CD group, but not HS. While the question of whether specific patterns of mR impairment reliably define a dystonic endophenotype remains elusive, our findings point to mR as a useful tool, when used carefully with control measures and tasks, which may be capable of identifying specific deficits that distinguish between subtypes of dystonia.
Inflammation in the brain and gut is a critical component of several neurological diseases, such as Parkinson’s disease (PD). One trigger of the immune system in PD is aggregation of the pre-synaptic protein, α-synuclein (αSyn). Understanding the mechanism of propagation of αSyn aggregates is essential to developing disease-modifying therapeutics. Using a brain-first mouse model of PD, we demonstrate αSyn trafficking from the brain to the ileum of male mice. Immunohistochemistry revealed that the ileal αSyn aggregations are contained within CD11c+ cells. Using single-cell RNA sequencing, we demonstrate that ileal CD11c\(^+\) cells are microglia-like and the same subtype of cells is activated in the brain and ileum of PD mice. Moreover, by utilizing mice expressing the photo-convertible protein, Dendra2, we show that CD11c\(^+\) cells traffic from the brain to the ileum. Together these data provide a mechanism of αSyn trafficking between the brain and gut.
Highlights
• Beta-Guided programming is an innovative approach that may streamline the programming process for PD patients with STN DBS.
• While preliminary findings from our study suggest that Beta Titration may potentially mitigate STN overstimulation and enhance symptom control,
• Our results demonstrate that beta-guided programming significantly reduces programming time, suggesting it could be efficiently integrated into routine clinical practice using a commercially available patient programmer.
Background
Subthalamic nucleus deep brain stimulation (STN-DBS) is an effective treatment for advanced Parkinson's disease (PD). Clinical outcomes after DBS can be limited by poor programming, which remains a clinically driven, lengthy and iterative process. Electrophysiological recordings in PD patients undergoing STN-DBS have shown an association between STN spectral power in the beta frequency band (beta power) and the severity of clinical symptoms. New commercially-available DBS devices now enable the recording of STN beta oscillations in chronically-implanted PD patients, thereby allowing investigation into the use of beta power as a biomarker for DBS programming.
Objective
To determine the potential advantages of beta-guided DBS programming over clinically and image-guided programming in terms of clinical efficacy and programming time.
Methods
We conducted a randomized, blinded, three-arm, crossover clinical trial in eight Parkinson's patients with STN-DBS who were evaluated three months after DBS surgery. We compared clinical efficacy and time required for each DBS programming paradigm, as well as DBS parameters and total energy delivered between the three strategies (beta-, clinically- and image-guided).
Results
All three programming methods showed similar clinical efficacy, but the time needed for programming was significantly shorter for beta- and image-guided programming compared to clinically-guided programming (p < 0.001).
Conclusion
Beta-guided programming may be a useful and more efficient approach to DBS programming in Parkinson's patients with STN-DBS. It takes significantly less time to program than traditional clinically-based programming, while providing similar symptom control. In addition, it is readily available within the clinical DBS programmer, making it a valuable tool for improving current clinical practice.
Idiopathic Parkinson’s disease (PD) is characterized by a progredient degeneration of the brain, starting at deep subcortical areas such as the dorsal motor nucleus of the glossopharyngeal and vagal nerves (DM) (stage 1), followed by the coeruleus–subcoeruleus complex; (stage 2), the substantia nigra (SN) (stage 3), the anteromedial temporal mesocortex (MC) (stage 4), high-order sensory association areas and prefrontal fields (HC) (stage 5) and finally first-order sensory association areas, premotor areas, as well as primary sensory and motor field (FC) (stage 6). Autoimmunity might play a role in PD pathogenesis. Here we analyzed whether anti-brain autoantibodies differentially recognize different human brain areas and identified autoantigens that correlate with the above-described dissemination of PD pathology in the brain. Brain tissue was obtained from deceased individuals with no history of neurological or psychiatric disease and no neuropathological abnormalities. Tissue homogenates from different brain regions (DM, SN, MC, HC, FC) were subjected to SDS-PAGE and Western blot. Blots were incubated with plasma samples from 30 PD patients and 30 control subjects and stained with anti-IgG antibodies to detect anti-brain autoantibodies. Signals were quantified. Prominent autoantigens were identified by 2D-gel-coupled mass spectrometry sequencing. Anti-brain autoantibodies are frequent and occur both in healthy controls and individuals with PD. Glial fibrillary acidic protein (GFAP) was identified as a prominent autoantigen recognized in all plasma samples. GFAP immunoreactivity was highest in DM areas and lowest in FC areas with no significant differences in anti-GFAP autoantibody titers between healthy controls and individuals with PD. The anti-GFAP autoimmunoreactivity of different brain areas correlates with the dissemination of histopathological neurodegeneration in PD. We hypothesize that GFAP autoantibodies are physiological but might be involved as a cofactor in PD pathogenesis secondary to a leakage of the blood–brain barrier.
Background
Eye movement abnormalities are commonplace in neurological disorders. However, unaided eye movement assessments lack granularity. Although videooculography (VOG) improves diagnostic accuracy, resource intensiveness precludes its broad use. To bridge this care gap, we here validate a framework for smartphone video-based nystagmography capitalizing on recent computer vision advances.
Methods
A convolutional neural network was fine-tuned for pupil tracking using > 550 annotated frames: ConVNG. In a cross-sectional approach, slow-phase velocity of optokinetic nystagmus was calculated in 10 subjects using ConVNG and VOG. Equivalence of accuracy and precision was assessed using the “two one-sample t-test” (TOST) and Bayesian interval-null approaches. ConVNG was systematically compared to OpenFace and MediaPipe as computer vision (CV) benchmarks for gaze estimation.
Results
ConVNG tracking accuracy reached 9–15% of an average pupil diameter. In a fully independent clinical video dataset, ConVNG robustly detected pupil keypoints (median prediction confidence 0.85). SPV measurement accuracy was equivalent to VOG (TOST p < 0.017; Bayes factors (BF) > 24). ConVNG, but not MediaPipe, achieved equivalence to VOG in all SPV calculations. Median precision was 0.30°/s for ConVNG, 0.7°/s for MediaPipe and 0.12°/s for VOG. ConVNG precision was significantly higher than MediaPipe in vertical planes, but both algorithms’ precision was inferior to VOG.
Conclusions
ConVNG enables offline smartphone video nystagmography with an accuracy comparable to VOG and significantly higher precision than MediaPipe, a benchmark computer vision application for gaze estimation. This serves as a blueprint for highly accessible tools with potential to accelerate progress toward precise and personalized Medicine.
Background and purpose
The aim was to characterize a combined vestibular, ocular motor and postural syndrome induced by deep brain stimulation (DBS) of the subthalamic nucleus in a patient with Parkinson's disease.
Methods
In a systematic DBS programming session, eye, head and trunk position in roll and pitch plane were documented as a function of stimulation amplitude and field direction. Repeat ocular coherence tomography was used to estimate ocular torsion. The interstitial nucleus of Cajal (INC), zona incerta (ZI) and ascending vestibular fibre tracts were segmented on magnetic resonance imaging using both individual and normative structural connectomic data. Thresholded symptom-associated volumes of tissue activated (VTA) were calculated based on documented stimulation parameters.
Results
Ipsilateral ocular tilt reaction and body lateropulsion as well as contralateral torsional nystagmus were elicited by the right electrode in a current-dependent manner and subsided after DBS deactivation. With increasing currents, binocular tonic upgaze and body retropulsion were observed. Symptoms were consistent with an irritative effect on the INC. Symptom-associated VTA was found to overlap with the dorsal ZI and the ipsilateral vestibulothalamic tract, while lying rather distant to the INC proper. A ZI-to-INC ‘incerto-interstitial’ tract with contact to the medial-uppermost portion of the VTA could be traced.
Conclusion
Unilateral stimulation of INC-related circuitry induces an ipsilateral vestibular, ocular motor and postural roll-plane syndrome, which converts into a pitch-plane syndrome when functional activation expands bilaterally. In this case, tractography points to an incerto-interstitial pathway, a tract previously only characterized in non-human primates. Directional current steering proved useful in managing this rare side effect.
The objective of this study was to examine the therapeutic potential of multiple sessions of training on a split-belt treadmill (SBT) combined with cerebellar anodal transcranial direct current stimulation (tDCS) on gait and balance in People with Multiple Sclerosis (PwMS). Twenty-two PwMS received six sessions of anodal (PwMS\(_{real}\), n = 12) or sham (PwMS\(_{sham}\), n = 10) tDCS to the cerebellum prior to performing the locomotor adaptation task on the SBT. To evaluate the effect of the intervention, functional gait assessment (FGA) scores and distance walked in 2 min (2MWT) were measured at the baseline (T0), day 6 (T5), and at the 4-week follow up (T6). Locomotor performance and changes of motor outcomes were similar in PwMS\(_{real}\) and PwMS\(_{sham}\) independently from tDCS mode applied to the cerebellum (anodal vs. sham, on FGA, p = 0.23; and 2MWT, p = 0.49). When the data were pooled across the groups to investigate the effects of multiple sessions of SBT training alone, significant improvement of gait and balance was found on T5 and T6, respectively, relative to baseline (FGA, p < 0.001 for both time points). The FGA change at T6 was significantly higher than at T5 (p = 0.01) underlining a long-lasting improvement. An improvement of the distance walked during the 2MWT was also observed on T5 and T6 relative to T0 (p = 0.002). Multiple sessions of SBT training resulted in a lasting improvement of gait stability and endurance, thus potentially reducing the risk of fall as measured by FGA and 2MWT. Application of cerebellar tDCS during SBT walking had no additional effect on locomotor outcomes.